Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 85, P. 101861 - 101861
Published: Jan. 21, 2023
Language: Английский
Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 85, P. 101861 - 101861
Published: Jan. 21, 2023
Language: Английский
Nature Reviews Nephrology, Journal Year: 2020, Volume and Issue: 16(5), P. 269 - 288
Published: Feb. 14, 2020
Language: Английский
Citations
705Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)
Published: March 17, 2023
Abstract Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney fibrosis, characterized by excessive extracellular matrix deposition leading scarring, a hallmark manifestation in different progressive CKD; However, at present no antifibrotic therapies against CKD exist. fibrosis identified tubule atrophy, interstitial chronic inflammation and fibrogenesis, glomerulosclerosis, vascular rarefaction. Fibrotic niche, where organ initiates, complex interplay between injured parenchyma (like tubular cells) multiple non-parenchymal cell lineages (immune mesenchymal located spatially within scarring areas. Although the mechanisms are complicated due kinds cells involved, with help single-cell technology, many key questions have been explored, such as what kind renal tubules profibrotic, myofibroblasts originate, which immune how communicate each other. In addition, genetics epigenetics deeper that regulate fibrosis. And reversible nature epigenetic changes including DNA methylation, RNA interference, chromatin remodeling, gives an opportunity stop or reverse therapeutic strategies. More marketed (e.g., RAS blockage, SGLT2 inhibitors) developed delay progression recent years. Furthermore, better understanding also favored discover biomarkers fibrotic injury. review, we update advances mechanism summarize novel treatment for CKD.
Language: Английский
Citations
282Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)
Published: June 9, 2022
Abstract Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that characterized by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) deposition. Lipotoxicity oxidative stress are the driving force for loss of including tubules, glomerulus, endothelium. NLRP3 inflammasome signaling, MAPK PI3K/Akt RAAS signaling involves in lipotoxicity. The upregulated Nox expression decreased Nrf2 result directly. injured resident cells release proinflammatory cytokines chemokines to recruit immune such as macrophages from bone marrow. NF-κB JAK-STAT Toll-like receptor cGAS-STING major pathways mediate inflammation inflammatory cells. produce secret great number profibrotic TGF-β1, Wnt ligands, angiotensin II. TGF-β Notch evoke activation promote generation ECM. potential therapies targeted these also introduced here. In this review, we update key lipotoxicity, stress, kidneys with injury, drugs based on latest studies. Unifying will be instrumental advance further basic clinical investigation CKD.
Language: Английский
Citations
227Biomedicine & Pharmacotherapy, Journal Year: 2021, Volume and Issue: 143, P. 112132 - 112132
Published: Sept. 1, 2021
Fibrosis is the endpoint of pathological remodeling. This process contributes to pathogenesis several chronic disorders and aging-associated organ damage. Different molecular cascades contribute this process. TGF-β, WNT, YAP/TAZ signaling pathways have prominent roles in A number long non-coding RNAs microRNAs been found regulate fibrosis through modulation activity related pathways. miR-144-3p, miR-451, miR-200b, miR-328 are among that participate pathology cardiac fibrosis. Meanwhile, miR-34a, miR-17-5p, miR-122, miR-146a, miR-350 liver different situations. PVT1, MALAT1, GAS5, NRON, PFL, MIAT, HULC, ANRIL, H19 We review impact aging-related pathologies.
Language: Английский
Citations
119Nature Reviews Nephrology, Journal Year: 2021, Volume and Issue: 17(8), P. 528 - 542
Published: May 10, 2021
Language: Английский
Citations
118Nature Reviews Nephrology, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 17, 2024
Language: Английский
Citations
19Nature Communications, Journal Year: 2021, Volume and Issue: 12(1)
Published: April 22, 2021
Language: Английский
Citations
101Frontiers in Physiology, Journal Year: 2020, Volume and Issue: 11
Published: July 9, 2020
Renal proximal tubular cells are high energy-demanding mainly relying on fatty acid oxidation. In stress conditions, such as transient hypoxia, oxidation (FAO) decreases and carbohydrate catabolism fails to compensate for the energy demand. this scenario, surviving exhibit peculiar phenotype associating with fibrosis that is histological manifestation of a process culminating in chronic end-stage kidney disease. Genome-wide transcriptome analysis revealed that, together inflammation, FAO top dysregulated pathway diseases lowered expression key enzymes regulators. Another evidence links derangement progressive decrease peroxisome proliferator-activated receptor α (PPARα), master regulator enzymes, aged people triggers age-associated renal fibrosis. To allow FAO, coordinate network transport proteins required. Indeed, mitochondrial inner membrane impermeable acyl-CoAs specialized system, well known carnitine shuttle, needed translocate acids moieties, conjugated carnitine, into matrix β-oxidation. The first component system palmitoyltransferase 1 (CPT1) responsible transfer acyl moieties carnitine. Several studies indicated stimulation CPT1 activity has protective effect against Therefore, transporters linked may represent potential pharmacological targets deserving further attention development new drugs attenuate dysfunction.
Language: Английский
Citations
88Antioxidants, Journal Year: 2022, Volume and Issue: 11(7), P. 1356 - 1356
Published: July 12, 2022
Acute kidney injury (AKI) and chronic disease (CKD) are interconnected conditions, CKD is projected to become the fifth leading global cause of death by 2040. New therapeutic approaches needed. Mitochondrial dysfunction oxidative stress have emerged as drivers in acute settings, promoting AKI-to-CKD transition. In this work, we review role mitochondrial AKI progression discuss novel approaches. Specifically, evidence for diverse models (nephrotoxicity, cytokine storm, ischemia-reperfusion injury) (diabetic disease, glomerulopathies) discussed; clinical implications information on key mitochondria-related transcriptional regulators peroxisome proliferator-activated receptor gamma coactivator 1-alpha, transcription factor EB (PGC-1α, TFEB), carnitine palmitoyl-transferase 1A (CPT1A) addressed; current status development targeting mitochondria updated; barriers mitochondria-targeted interventions discussed, including lack diagnostic tests that allow us categorize baseline renal dysfunction/mitochondrial monitor its response intervention. Finally, milestones further research proposed.
Language: Английский
Citations
64Cells, Journal Year: 2021, Volume and Issue: 10(3), P. 541 - 541
Published: March 4, 2021
The delivery of cancer therapeutics can be limited by pharmacological issues such as poor bioavailability and high toxicity to healthy tissue. pH-low insertion peptides (pHLIPs) represent a promising tool overcome these limitations. pHLIPs allow for the selective agents tumors on basis pH, taking advantage acidity hypoxic tumor microenvironment. This review article highlights various applications in which have been utilized targeting treating diseases environments, including small molecule inhibitors, toxins, nucleic acid analogs, fluorescent dyes, nanoparticles.
Language: Английский
Citations
60